ropocamptide has been researched along with Sepsis* in 1 studies
1 other study(ies) available for ropocamptide and Sepsis
Article | Year |
---|---|
Naturally occurring antimicrobial peptide OH-CATH30 selectively regulates the innate immune response to protect against sepsis.
Sepsis, which is a systemic inflammatory response that follows a bacterial infection, has a high mortality rate and limited therapeutic options. Here we show that the antimicrobial peptide OH-CATH30, which naturally occurs in snake, selectively regulates the innate immune response to protect mice from lethal sepsis. The administration of OH-CATH30 significantly improves the survival rate of mice infected by antibiotic-susceptible and -resistant pathogens, including Escherichia coli , Pseudomonas aeruginosa , and Staphylococcus aureus . OH-CATH30 selectively up-regulates the production of chemokines and cytokines without harmful immune response. Recruitment of monocytes, macrophages, and neutrophils to the infection site is pivotal to the protective capacity of OH-CATH30. Furthermore, the alternative activation of the innate immune response by OH-CATH30 depends on p38 mitogen-activated protein kinase signaling. Taken together, our study demonstrates that OH-CATH30, a naturally occurring antimicrobial peptide, selectively stimulates the innate immune response to protect against sepsis. Topics: Amino Acid Sequence; Animals; Anti-Bacterial Agents; Biological Products; Cell Line; Chemokine CXCL2; Drug Resistance, Bacterial; Female; Humans; Immunity, Innate; Immunomodulation; Macrophages; MAP Kinase Signaling System; Mice; Molecular Sequence Data; Monocytes; Neutrophils; p38 Mitogen-Activated Protein Kinases; Peptides; Sepsis | 2013 |